All In Biotech

Free tool

FAERS Monitor: Medrol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 011153 or its brand name (Medrol, Methylprednisolone). Reports on generic versions are filed under their own applications.

Reports

124,181

Serious

110,690

89% of reports

Hospitalization

51,149

Death reported

19,405

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use18,660
  • drug ineffective14,392
  • fatigue6,387
  • nausea6,032
  • pain5,898
  • headache5,777
  • pneumonia5,729
  • pyrexia5,721
  • dyspnoea5,449
  • arthralgia5,351
  • diarrhoea5,294
  • condition aggravated5,023
  • product use in unapproved indication4,933
  • rash4,229
  • hypertension4,196

Reports by year received

View as table
YearReports
2004825
2005878
2006944
2007826
20081,124
20091,138
20101,855
20112,377
20122,922
20132,671
20143,195
20153,989
20164,632
20175,753
20188,014
20199,407
202012,161
202111,536
202211,383
202310,448
202410,700
202510,662
20266,733

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,929,978 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
off label useSignal18,6603.73.636,945
product use in unapproved indicationSignal4,9333.43.38,372
hypertensionSignal4,1963.43.37,048
pneumoniaSignal5,7293.03.07,787
pyrexiaSignal5,7212.82.86,771
condition aggravatedSignal5,0232.82.85,923
arthralgiaSignal5,3512.22.13,505
drug ineffective14,3921.91.86,027
rash4,2291.61.61,093
dyspnoea5,4491.61.61,372
pain5,8981.61.61,473
headache5,7771.61.51,206
fatigue6,3871.41.4728
diarrhoea5,2941.41.4598
nausea6,0321.31.3413

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.